Convergence of Precision Oncology and Liquid Biopsy in Non-Small Cell Lung Cancer

被引：7
|
作者：
Al-Obeidi, Ebaa [1 ]
Riess, Jonathan W. [1 ]
Malapelle, Umberto [2 ]
Rolfo, Christian [3 ]
Gandara, David R. [1 ]
机构：
[1] Univ Calif Davis, Div Hematol Oncol, 4501 10 St,Suite 3016, Sacramento, CA 95817 USA
[2] Univ Naples Federico II, Dept Publ Hlth, Via Sergio Pansini 5, I-80131 Naples, Italy
[3] Icahn Sch Med Mt Sinai, Ctr Thorac Oncol, Tisch Canc Inst, One Gustave Levy Pl,Box 1079, New York, NY 10029 USA
来源：
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2023年 / 37卷 / 03期
关键词：
Liquid biopsy; Circulating tumor DNA (ctDNA); Next-generation sequencing (NGS); Minimal residual disease (MRD); Tumor mutational burden (TMB); Non-small cell lung cancer (NSCLC); CIRCULATING TUMOR DNA; RESIDUAL DISEASE; CLINICAL UTILITY; RESISTANCE; LANDSCAPE; BLOCKADE;
D O I：
10.1016/j.hoc.2023.02.005
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：475 / 487
页数：13
相关论文
共 50 条
  • [41] The economic value of liquid biopsy for genomic profiling in advanced non-small cell lung cancer
    Ezeife, Doreen A.
    Spackman, Eldon
    Juergens, Rosalyn A.
    Laskin, Janessa J.
    Agulnik, Jason S.
    Hao, Desiree
    Laurie, Scott A.
    Law, Jennifer H.
    Le, Lisa W.
    Kiedrowski, Lesli A.
    Melosky, Barbara
    Shepherd, Frances A.
    Cohen, Victor
    Wheatley-Price, Paul
    Vandermeer, Rachel
    Li, Janice J.
    Fernandes, Roxanne
    Shokoohi, Aria
    Lanman, Richard B.
    Leighl, Natasha B.
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14
  • [42] Liquid biopsy in non-small cell lung cancer: a key role in the future of personalized medicine?
    Pi, Can
    Zhang, Ming-feng
    Peng, Xiao-xiao
    Zhang, Yi-chen
    Xu, Chong-rui
    Zhou, Qing
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2017, 17 (12) : 1089 - 1096
  • [43] Circular RNAs Are Promising Biomarkers in Liquid Biopsy for the Diagnosis of Non-small Cell Lung Cancer
    Huang, Lanxiang
    Rong, Yuan
    Tang, Xuan
    Yi, Kezhen
    Wu, Jianyuan
    Wang, Fubing
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2021, 8
  • [44] The Economic Value of Liquid Biopsy for Genomic Profiling in Advanced Non-Small Cell Lung Cancer
    Ezeife, D.
    Spackman, E.
    Juergens, R.
    Laskin, J.
    Agulnik, J.
    Hao, D.
    Laurie, S.
    Law, J.
    Le, L.
    Kiedrowski, L.
    Melosky, B.
    Shepherd, F. A.
    Cohen, V.
    Wheatley-Price, P.
    Vandermeer, R.
    Li, J.
    Fernandes, R.
    Shokoohi, A.
    Lanman, R.
    Leighl, N.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S876 - S876
  • [45] Mutation analysis in liquid biopsy from Lithuanian non-small cell lung cancer patients
    Jarmalaite, S.
    Sestokaite, A.
    Gedvilaite, V.
    Sabaliauskaite, R.
    Cicenas, S.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2020, 28 (SUPPL 1) : 542 - 543
  • [46] Circulating circTOLLIP serves as a diagnostic biomarker for liquid biopsy in non-small cell lung cancer
    Peng, Ziyi
    Hu, Qiuzhi
    Fang, Shuai
    Zhang, Xun
    Hong, Xin
    Tao, Lili
    Pan, Jinchang
    Jiang, Meina
    Bai, Huihui
    Wu, Yinuo
    Zhao, Xiaodong
    Zhou, Chengwei
    Chen, Jun
    Han, Ying
    Gong, Zhaohui
    CLINICA CHIMICA ACTA, 2021, 523 : 415 - 422
  • [47] The emerging roles of NGS-based liquid biopsy in non-small cell lung cancer
    Zhang, Yi-Chen
    Zhou, Qing
    Wu, Yi-Long
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2017, 10
  • [48] The emerging roles of NGS-based liquid biopsy in non-small cell lung cancer
    Yi-Chen Zhang
    Qing Zhou
    Yi-Long Wu
    Journal of Hematology & Oncology, 10
  • [49] Molecular profiling of non-small cell lung cancer (NSCLC) - the liquid biopsy comes of age
    Pender, A.
    Garcia-Murillas, I.
    de Castro, D. Gonzalez
    Popat, S.
    Downward, J.
    LUNG CANCER, 2014, 83 : S5 - S5
  • [50] Characterization of the tumor microenvironment and liquid biopsy in head and neck and non-small cell lung cancer
    Kulasinghe, Arutha
    Kapeleris, Joanna
    Kenny, Liz
    Hughes, Brett
    Warkiani, Majid
    Vela, Ian
    Thiery, Jean-Paul
    O'Byrne, Ken
    Punyadeera, Chamindie
    CANCER RESEARCH, 2020, 80 (16)
12345